Gene Expression Classification for Chemical Sensitizer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting the allergic potential of chemical compounds are inadequate, as they are often slow, expensive, and lack high-throughput capabilities, and there is a need for non-animal models to assess sensitizing potential due to ethical and economic concerns, particularly for the 30,000 chemicals that need to be tested for toxicity by 2012.
Innovation Solution
A method involving a cell culture of specific cell types, such as CD34-DC cells, where gene expressions are analyzed for a subset of genes using a statistical classification model trained on a database of known sensitizers and non-sensitizers, allowing for the prediction of a chemical compound's sensitizing potential by exposing test and control samples to the compound and comparing gene expressions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods are used to test chemical compounds for allergic potential, then measurement precision may be adequate, but productivity is low and loss of time is high
Solution Approach 1:
The patent segments the complex allergic response into specific gene expression changes that can be measured independently. By focusing on a subset of genes (i=1 to n) from a larger candidate gene set, the method divides the testing process into manageable molecular components that can be analyzed in parallel, thereby increasing productivity while maintaining measurement precision through targeted gene expression analysis.
Solution Approach 2:
The patent replaces traditional in vivo animal testing (mechanical/biological system) with an in vitro cell culture-based gene expression analysis system. This substitution uses statistical classification models applied to molecular data (gene expressions) rather than observing physiological responses in living organisms, dramatically increasing testing speed and productivity while maintaining or improving measurement precision through quantifiable molecular markers.
2Loss of time
If comprehensive testing of all 30,000 chemicals is conducted using traditional methods, then measurement precision is maintained, but loss of time and economic cost increase significantly
Solution Approach 1:
The patent performs preliminary action by establishing a training phase where statistical classification models are pre-trained on gene expression data from known sensitizers and non-sensitizers. This preliminary model development allows rapid classification of new chemicals without requiring time-consuming in vivo testing for each compound, thereby reducing loss of time while maintaining measurement precision through the validated classification framework.
Solution Approach 2:
The patent changes the measurement parameters from observing complex physiological responses in living organisms to measuring specific gene expression levels (xi for i=1 to n). This parameter change transforms the testing approach into a high-throughput molecular assay that can be performed rapidly on cell cultures, significantly reducing testing duration for all 30,000 chemicals while maintaining or improving accuracy through quantitative molecular data and statistical classification.
3Reliability
If animal testing is used to ensure accurate prediction of sensitizing potential, then measurement precision is high, but ethical concerns and economic burden increase
Solution Approach 1:
The patent creates a simplified copy of the allergic response system using cell cultures (such as dendritic cells or Langerhans cells) instead of complete living organisms. This cellular model copy reproduces the key immunological events (antigen presentation, T-cell activation) that occur in vivo during sensitization, allowing reliable prediction of sensitizing potential without the ethical concerns and economic costs of animal experimentation while maintaining measurement precision through controlled molecular measurements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a fast, inexpensive, and high-throughput approach to determine the allergic potential of chemical compounds, enabling quick identification of sensitizers and non-sensitizers, thereby reducing the need for animal testing and addressing the economic burden of contact dermatitis.
Implementation Method 1
Determining for the test sample and the control sample gene expressions xi for a subset of i=1 to n genes
Data Source
AI summary
The present invention is related to a method for determining the sensitizing potential of a chemical (test) compound, comprising the steps of:(a) Providing a suitable cell culture of a specific cell type and providing a test sample and a control sample thereof, said test sample and said control sample being identical,(b) Exposing said test sample to a chemical compound in a solvent and exposing said control sample to said solvent for a predetermined period of time,(c) Determining for the test sample and the control sample gene expressions xi for a subset of i=1 to n genes selected from the group of genes corresponding to SEQ ID NOs 1 to 153,(d) For this subset of n genes looking up in a database the gene expressions xi for a set of control and test samples, the test samples being exposed for said predetermined period of time to a set of chemical sensitizing model compounds comprising both sensitizers and non-sensitizers,(e) Using the gene expressions of the said test sample and the said control sample of step (c) as input to a statistical classification model that is based on said database and that is trained and optimized to classify chemical compounds as either sensitizers or non-sensitizers using gene expressions xi for said subset of n genes, and(f) Predicting through said model whether the chemical compound tested belongs to the class of sensitizers or to the class of non-sensitizers.